The latest closing stock price for Immunovant as of February 24, 2025 is 20.43.
An investor who bought $1,000 worth of Immunovant stock at the IPO in 2020 would have $202 today, roughly 0 times their original investment - a 3.74% compound annual growth rate over 5 years.
The all-time high Immunovant stock closing price was 52.71 on November 17, 2020.
The Immunovant 52-week high stock price is 38.31, which is 87.5% above the current share price.
The Immunovant 52-week low stock price is 19.07, which is 6.7% below the current share price.
The average Immunovant stock price for the last 52 weeks is 28.17.
An investor who bought $1,000 worth of Immunovant stock at the IPO in 2020 would have $202 today, roughly 0 times their original investment - a 3.74% compound annual growth rate over 5 years.
The all-time high Immunovant stock closing price was 52.71 on November 17, 2020.
The Immunovant 52-week high stock price is 38.31, which is 87.5% above the current share price.
The Immunovant 52-week low stock price is 19.07, which is 6.7% below the current share price.
The average Immunovant stock price for the last 52 weeks is 28.17.